We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$415M
AUM Growth
-$4.33M
Cap. Flow
-$18.3M
Cap. Flow %
-4.42%
Top 10 Hldgs %
32.16%
Holding
110
New
9
Increased
26
Reduced
44
Closed
15

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$7.38M
2
QCOM icon
Qualcomm
QCOM
+$4.27M
3
TEL icon
TE Connectivity
TEL
+$3.41M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.34M
5
MYGN icon
Myriad Genetics
MYGN
+$3.26M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$5.24M
2
MA icon
Mastercard
MA
+$4.57M
3
MMM icon
3M
MMM
+$4.46M
4
AAPL icon
Apple
AAPL
+$4.31M
5
MET icon
MetLife
MET
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 30.73%
2 Financials 14.73%
3 Industrials 11.42%
4 Technology 9.34%
5 Consumer Discretionary 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
76
IBM
IBM
$203B
$481K 0.12%
2,615
+209
+9% +$36.8K
ATHN
77
DELISTED
Athenahealth, Inc.
ATHN
$481K 0.12%
3,000
– –
ADP icon
78
Automatic Data Processing
ADP
$99.3B
$475K 0.11%
7,005
+513
+8% +$34.9K
WASH icon
79
Washington Trust Bancorp
WASH
$734M
$470K 0.11%
12,545
-155
-1% -$5.46K
KMR
80
DELISTED
KINDER MORGAN MANAGEMENT LLC
KMR
$446K 0.11%
6,540
-2,079
-24% -$144K
OGS icon
81
ONE Gas
OGS
$5.05B
$422K 0.1%
+11,749
New +$404K
BRK.B icon
82
Berkshire Hathaway Class B
BRK.B
$1.07T
$409K 0.1%
3,274
+774
+31% +$90.4K
TMO icon
83
Thermo Fisher Scientific
TMO
$209B
$337K 0.08%
2,800
– –
CVS icon
84
CVS Health
CVS
$137B
$285K 0.07%
3,806
– –
UNP icon
85
Union Pacific
UNP
$183B
$278K 0.07%
2,964
– –
GE icon
86
GE Aerospace
GE
$369B
$267K 0.06%
2,149
-271
-11% -$33.5K
IART icon
87
Integra LifeSciences
IART
$1.54B
$251K 0.06%
13,377
– –
ECL icon
88
Ecolab
ECL
$75.5B
$243K 0.06%
2,250
– –
INTC icon
89
Intel
INTC
$481B
$236K 0.06%
9,141
– –
ORCL icon
90
Oracle
ORCL
$342B
$233K 0.06%
5,700
– –
USB icon
91
US Bancorp
USB
$99.6B
$228K 0.06%
+5,309
New +$218K
AMX icon
92
America Movil
AMX
$78.4B
$225K 0.05%
11,310
-800
-7% -$16.6K
PFE icon
93
Pfizer
PFE
$140B
$201K 0.05%
+6,595
New +$197K
ABT icon
94
Abbott
ABT
$180B
$200K 0.05%
5,200
-477
-8% -$18.4K
GCVRZ
95
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$13K ﹤0.01%
+40,300
New +$15K
CLF icon
96
Cleveland-Cliffs
CLF
$6.66B
– –
-81,300
Closed -$2.13M
DHI icon
97
D.R. Horton
DHI
$40.8B
– –
-16,800
Closed -$374K
HMC icon
98
Honda
HMC
$36.7B
– –
-50,000
Closed -$2.07M
HOLX
99
DELISTED
Hologic
HOLX
– –
-9,150
Closed -$204K
HRI icon
100
Herc Holdings
HRI
$5.47B
– –
-30,700
Closed -$2.63M
1 2 3
4
5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q1 2014 Portfolio in Review

As of Q1 2014, De Burlo Group held 110 positions worth $415M, down 1% from $419M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

De Burlo Group withdrew a net $18.3M in Q1 2014, closing 15 positions and reducing 44 holdings. Its most notable exit was Corpay, an estimated $3.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.

Against the trend, De Burlo Group opened a new position in SALIX PHARMACEUTICALS LTD DEL worth $7.47M.

  • De Burlo Group's largest Q1 2014 buy was SALIX PHARMACEUTICALS LTD DEL: 72,100 shares worth $7.47M.
  • De Burlo Group added most to Qualcomm in Q1 2014, an estimated $4.27M increase.
  • De Burlo Group's biggest Q1 2014 reduction was Illumina, cutting an estimated $5.24M.
  • De Burlo Group fully exited Corpay in Q1 2014, selling an estimated $3.16M.
  • De Burlo Group's ten largest holdings make up 32% of its $415M portfolio in Q1 2014.
  • De Burlo Group opened 9 new positions and closed 15 in Q1 2014.
  • De Burlo Group's portfolio value fell 1% quarter-over-quarter to $415M.

Based on De Burlo Group's 13F filing for Q1 2014, filed 8 May 2014.